Cargando…
Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence
Irritable Bowel Syndrome (IBS) is a chronic, one of the commonest and persistent gastrointestinal (GI) disorder. Previously, the management plan for IBS-D included enhancing awareness; first line treatment included an increased dietary fiber intake, opioids for diarrhea and antispasmodics for pain m...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129270/ https://www.ncbi.nlm.nih.gov/pubmed/37113818 http://dx.doi.org/10.1097/MS9.0000000000000338 |
_version_ | 1785030697149267968 |
---|---|
author | Shaikh, Omer Ahmed Shaikh, Gulrukh Aftab, Rameel Muhammad Baktashi, Haisum Ullah, Irfan Asghar, Muhammad Sohaib |
author_facet | Shaikh, Omer Ahmed Shaikh, Gulrukh Aftab, Rameel Muhammad Baktashi, Haisum Ullah, Irfan Asghar, Muhammad Sohaib |
author_sort | Shaikh, Omer Ahmed |
collection | PubMed |
description | Irritable Bowel Syndrome (IBS) is a chronic, one of the commonest and persistent gastrointestinal (GI) disorder. Previously, the management plan for IBS-D included enhancing awareness; first line treatment included an increased dietary fiber intake, opioids for diarrhea and antispasmodics for pain management. A recent treatment guideline by the American Gastroenterology Association (AGA) suggests a modified approach to treating patients with IBS-D. Eight drug recommendations were made, and a set of instructions on when to employ which medication was devised. With the incorporation of these structured guidelines, a more tailored and focused approach to IBS management may become plausible. |
format | Online Article Text |
id | pubmed-10129270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101292702023-04-26 Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence Shaikh, Omer Ahmed Shaikh, Gulrukh Aftab, Rameel Muhammad Baktashi, Haisum Ullah, Irfan Asghar, Muhammad Sohaib Ann Med Surg (Lond) Correspondence, Commentaries and Perspectives Irritable Bowel Syndrome (IBS) is a chronic, one of the commonest and persistent gastrointestinal (GI) disorder. Previously, the management plan for IBS-D included enhancing awareness; first line treatment included an increased dietary fiber intake, opioids for diarrhea and antispasmodics for pain management. A recent treatment guideline by the American Gastroenterology Association (AGA) suggests a modified approach to treating patients with IBS-D. Eight drug recommendations were made, and a set of instructions on when to employ which medication was devised. With the incorporation of these structured guidelines, a more tailored and focused approach to IBS management may become plausible. Lippincott Williams & Wilkins 2023-03-27 /pmc/articles/PMC10129270/ /pubmed/37113818 http://dx.doi.org/10.1097/MS9.0000000000000338 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Correspondence, Commentaries and Perspectives Shaikh, Omer Ahmed Shaikh, Gulrukh Aftab, Rameel Muhammad Baktashi, Haisum Ullah, Irfan Asghar, Muhammad Sohaib Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence |
title | Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence |
title_full | Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence |
title_fullStr | Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence |
title_full_unstemmed | Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence |
title_short | Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence |
title_sort | unconventional but effective: breaking through ibs-d clinical practice guidelines – correspondence |
topic | Correspondence, Commentaries and Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129270/ https://www.ncbi.nlm.nih.gov/pubmed/37113818 http://dx.doi.org/10.1097/MS9.0000000000000338 |
work_keys_str_mv | AT shaikhomerahmed unconventionalbuteffectivebreakingthroughibsdclinicalpracticeguidelinescorrespondence AT shaikhgulrukh unconventionalbuteffectivebreakingthroughibsdclinicalpracticeguidelinescorrespondence AT aftabrameelmuhammad unconventionalbuteffectivebreakingthroughibsdclinicalpracticeguidelinescorrespondence AT baktashihaisum unconventionalbuteffectivebreakingthroughibsdclinicalpracticeguidelinescorrespondence AT ullahirfan unconventionalbuteffectivebreakingthroughibsdclinicalpracticeguidelinescorrespondence AT asgharmuhammadsohaib unconventionalbuteffectivebreakingthroughibsdclinicalpracticeguidelinescorrespondence |